May 02, 2019

Merrill Insight | Healthcare M&A Spotlight

Healthcare encompasses a multitude of ecosystems, from drug development to digital health to health services. Though each sub-sector remains unique, common drivers, headwinds and due diligence best practices define activity across the industry.

What common DNA threads are savvy dealmakers tracking? 

In this video, watch a cross-section of healthcare M&A specialists discuss big picture trends and due diligence issues impacting the industry today. Answer polls on hot topics and benchmark yourself against your peers in real-time. 

Our panelists:

  • Andrew Kaplan, Principal, Bain Capital Private Equity 
  • Kelly Gold, Vice President, Corporate Development & Finance, CAMP4
  • Christopher French, Managing Director, CG / Petsky Prunier

This is your chance to take a quick reset and test current thinking against your peers. 

Sign up and join us for this relevant and vital conversation.

You may also like:

Q4 Corporate Update | Dealmakers debrief on 2022

Join us on Thursday, December 8 at 2 p.m. ET / 11 a.m. PT for the final installment of our 2022 quarterly roundtable series during this live webinar to hear what's on the minds of our expert panelists as we look ahead at 2023.

1344913240
What are the prospects for European M&A in 2023?

The Financial Times – in partnership with Datasite – will provide a key forward-looking market outlook for the EMEA M&A market and explore the risks and opportunities that this new dealmaking environment presents.